HEALTH IN CODE

About:

HIC is the European leader on genetic diagnosis of inherited cardiovascular diseases;from diagnostic to prognostic

Website: http://www.healthincode.com

Twitter/X: _healthincode

Top Investors: Xesgalicia, CRB Inverbío

Description:

HIC’s foundational mission is “the identification of health problems that may benefit from a genetic diagnosis, and the development and provision of genetic testing services for those conditions”. Since the beginning of the company, our main differential value is the combination of Knowledge Management tools with an expert dedicated multidisciplinary team, which allows us to provide a unique level of interpretation for the best genotyping. Currently HIC is specialized in high quality sequencing services and in the interpretation of genetic tests, providing clinicians with the tool to offer personalized medical care. HIC is the European leader on genetic diagnosis of inherited cardiovascular diseases and constantly extending its scope to other diseases: dyslipidemias, skeletal myopathies and most recently, cancer.

Total Funding Amount:

3.4M EUR

Headquarters Location:

A Coruña, Galicia, Spain

Founded Date:

2006-06-01

Contact Email:

info(AT)healthincode.com

Founders:

Lorenzo Monserrat

Number of Employees:

251-500

Last Funding Date:

2012-09-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai